Lymphoma, T-Cell, Cutaneous Clinical Trials

Completed

Treatment for Chronic Pain in Patients With Advanced Cancer

NCT00003687

Conditions: Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +93 more
Locations: Cross Cancer Institute Edmonton, Alberta, Canada

Newfoundland Cancer Treatment and Research Foundation St. John's, Newfoundland and Labrador, Canada

Princess Margaret Hospital Toronto, Ontario, Canada

McGill University Montreal, Quebec, Canada

View Trial Details

Completed

Panobinostat and Everolimus in Treating Patients With Recurrent Multiple Myeloma, Non-Hodgkin Lymphoma, or Hodgkin Lymphoma

NCT00918333

Conditions: Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, +75 more
Locations: Mayo Clinic in Arizona Scottsdale, Arizona, United States

Mark O Hatfield-Warren Grant Magnuson Clinical Center Bethesda, Maryland, United States

Mayo Clinic Rochester, Minnesota, United States

View Trial Details

Completed

Clinical Study Assessing Outcomes, Adverse Events, Treatment Patterns, and Quality of Life in Patients Diagnosed With Mycosis Fungoides Cutaneous T-cell Lymphoma

NCT02296164

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: Investigator Site Little Rock, Arkansas, United States

Investigator Site Duarte, California, United States

Investigator Site La Mesa, California, United States

Investigator Site San Francisco, California, United States

View all 36 locations

View Trial Details

Completed

Alemtuzumab, Fludarabine Phosphate, and Low-Dose Total Body Irradiation Before Donor Stem Cell Transplantation in Treating Patients With Hematological Malignancies

NCT00040846

Conditions: Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), +164 more
Locations: Presbyterian - Saint Lukes Medical Center - Health One Denver, Colorado, United States

Huntsman Cancer Institute/University of Utah Salt Lake City, Utah, United States

LDS Hospital Salt Lake City, Utah, United States

VA Puget Sound Health Care System Seattle, Washington, United States

View Trial Details

Completed

Tacrolimus and Mycophenolate Mofetil in Preventing Graft-Versus-Host Disease in Patients Who Have Undergone Total-Body Irradiation With or Without Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant for Hematologic Cancer

NCT00089011

Conditions: Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, +250 more
Locations: Huntsman Cancer Institute/University of Utah Salt Lake City, Utah, United States

LDS Hospital Salt Lake City, Utah, United States

VA Puget Sound Health Care System Seattle, Washington, United States

Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Completed

Fludarabine Phosphate and Total-Body Radiation Followed by Donor Peripheral Blood Stem Cell Transplant and Immunosuppression in Treating Patients With Hematologic Malignancies

NCT00014235

Conditions: Acute Myeloid Leukemia/Transient Myeloproliferative Disorder, Acute Undifferentiated Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, +159 more
Locations: University of Arizona Health Sciences Center Tucson, Arizona, United States

City of Hope Medical Center Duarte, California, United States

Stanford University Hospitals and Clinics Stanford, California, United States

OHSU Knight Cancer Institute Portland, Oregon, United States

View Trial Details

Completed

Fludarabine Phosphate, Low-Dose Total-Body Irradiation, and Donor Stem Cell Transplant Followed by Cyclosporine, Mycophenolate Mofetil, Donor Lymphocyte Infusion in Treating Patients With Hematopoietic Cancer

NCT00006251

Conditions: Acute Undifferentiated Leukemia, Adenocarcinoma, Adult Nasal Type Extranodal NK/T-cell Lymphoma, +152 more
Locations: Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States

University of Torino Torino, Italy

View Trial Details

Completed

Mycophenolate Mofetil and Cyclosporine in Reducing Graft-Versus-Host Disease in Patients With Hematologic Malignancies or Metastatic Kidney Cancer Undergoing Donor Stem Cell Transplant

NCT00078858

Conditions: Accelerated Phase Chronic Myelogenous Leukemia, Adenocarcinoma, Adult Acute Lymphoblastic Leukemia in Remission, +220 more
Locations: Stanford University Hospitals and Clinics Stanford, California, United States

Rocky Mountain Cancer Centers-Midtown Denver, Colorado, United States

Emory University/Winship Cancer Institute Atlanta, Georgia, United States

OHSU Knight Cancer Institute Portland, Oregon, United States

View Trial Details

Completed

Safety and Efficacy Study of a Dual PI3K Delta/Gamma Inhibitor in T-cell Lymphoma

NCT02567656

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: City of Hope Duarte, California, United States

Chao Family Comprehensive Cancer Center University of California Irvine Orange, California, United States

University of Colorado Cancer Center Aurora, Colorado, United States

Emory University School of Medicine Atlanta, Georgia, United States

View Trial Details

Completed

Study of Pralatrexate in Patients With Relapsed or Refractory Cutaneous T-cell Lymphoma

NCT00554827

Conditions: Cutaneous T-Cell Lymphoma, Disease Attributes, Hemic and Lymphatic Diseases, +15 more
Locations: City of Hope National Medical Center Duarte, California, United States

Stanford University School of Medicine Redwood City, California, United States

Yale University School of Medicine New Haven, Connecticut, United States

Emory University Atlanta, Georgia, United States

View Trial Details

Lymphoma, T-Cell, Cutaneous

Lymphoma, T-Cell, Cutaneous trial results

Related conditions